Cart
sales@molnova.com
Eclitasertib
CAS No. 2125450-76-0
Eclitasertib( DNL-758 | SAR-443122 )
Catalog No. M28842 CAS No. 2125450-76-0
Eclitasertib is a potent inhibitor of receptor-interacting protein kinase 1 (RIPK1, IC50 of <1 μΜ).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 260 | Get Quote |
|
| 10MG | 417 | Get Quote |
|
| 25MG | 687 | Get Quote |
|
| 50MG | 963 | Get Quote |
|
| 100MG | 1287 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEclitasertib
-
NoteResearch use only, not for human use.
-
Brief DescriptionEclitasertib is a potent inhibitor of receptor-interacting protein kinase 1 (RIPK1, IC50 of <1 μΜ).
-
DescriptionEclitasertib is a potent inhibitor of receptor-interacting protein kinase 1 (RIPK1, IC50 of <1 μΜ).
-
In Vitro——
-
In Vivo——
-
SynonymsDNL-758 | SAR-443122
-
PathwayApoptosis
-
TargetRIP kinase
-
RecptorGLUT
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2125450-76-0
-
Formula Weight378.38
-
Molecular FormulaC19H18N6O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (330.36 mM)
-
SMILESCN(c1ncccc1OC[C@@H]1NC(c2nc(Cc3ccccc3)n[nH]2)=O)C1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Liu KG, et al. Discovery and Optimization of Glucose Uptake Inhibitors. J Med Chem. 2020;63(10):5201-5211.
molnova catalog
related products
-
RIPGBM
RIPGBM is a cell type-selective, small molecule inducer of apoptosis in GBM cancer stem cells (CSCs) with EC50 of 220 nM (GBM 1 cells).
-
RIPA-56
A highly potent, selective, stable Receptor-interacting protein 1 (RIP1) inhibitor with IC50 of 13 nM.
-
RIP2 Kinase Inhibito...
RIP2 Kinase Inhibitor 3 is a potent and selective inhibitor of RIP2, demonstrating an IC50 of 1 nM.
